- Report
- October 2024
- 196 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- March 2025
- 196 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- January 2025
- 75 Pages
Global
From €4767EUR$4,995USD£3,994GBP
- Report
- April 2023
- 120 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- May 2023
- 113 Pages
Global
From €3500EUR$3,929USD£3,035GBP
The Bone Marrow Aspirate Concentrate (BMAC) market is a subset of the stem cell industry. BMAC is a type of stem cell therapy that involves harvesting stem cells from a patient's bone marrow and concentrating them for use in regenerative medicine. BMAC is used to treat a variety of conditions, including musculoskeletal injuries, autoimmune diseases, and degenerative diseases.
BMAC is a relatively new technology, and the market is still in its early stages of development. However, it is growing rapidly, as more and more patients are turning to stem cell therapies for their medical needs. The market is expected to continue to grow as more research is conducted and more treatments become available.
Several companies are involved in the BMAC market, including Osiris Therapeutics, Athersys, and Mesoblast. These companies are involved in the research, development, and commercialization of BMAC therapies. They are also involved in the manufacturing and distribution of BMAC products. Show Less Read more